AdvertisementFDA Challenges Stem Cell Companies As Patients Run Out Of TimeFebruary 02, 2013NPR StafffacebookEmailScientists have seen promise in the potential of stem cells, but not everyone agrees stem cell replacement therapy is ready for prime time. (U.S. Food and Drug Administration)
